feed,title,long_url,short_url
PubMed,[Biosens Bioelectron] Engineering a NanoBiT biosensor for detecting angiotensin-converting enzyme-2 (hACE2) interaction with SARS-CoV-2 spike protein and screening the inhibitors to block hACE2 and spike interaction,https://pubmed.ncbi.nlm.nih.gov/39102773,
PubMed,[Health Expect] Which factors drive the choice of the French-speaking Quebec population towards a COVID-19 vaccination programme: A discrete-choice experiment,https://pubmed.ncbi.nlm.nih.gov/39102733,
PubMed,[Health Expect] Exploring the experiences and preferences of South Asian patients' of primary care in England since COVID-19,https://pubmed.ncbi.nlm.nih.gov/39102699,
PubMed,"[JMIR Bioinform Biotechnol] Correction: Mutations of SARS-CoV-2 Structural Proteins in the Alpha, Beta, Gamma, and Delta Variants: Bioinformatics Analysis",https://pubmed.ncbi.nlm.nih.gov/39102687,
PubMed,"[Health Aff (Millwood)] COVID-19 Federal Funding To Health Centers: Tracking Distribution, Locations, And Patient Characteristics",https://pubmed.ncbi.nlm.nih.gov/39102596,
PubMed,[J Appl Gerontol] Psychotherapy Engagement Before and After a Rapid Transition to Telehealth During COVID-19 for Older Adults With Dementia,https://pubmed.ncbi.nlm.nih.gov/39102577,
PubMed,[PLoS Pathog] SARS-CoV-2 spike-induced syncytia are senescent and contribute to exacerbated heart failure,https://pubmed.ncbi.nlm.nih.gov/39102426,
PubMed,[PLoS One] Incidence and risk factors of SARS-CoV-2 breakthrough infection in the early Omicron variant era among vaccinated and boosted individuals in Chicago,https://pubmed.ncbi.nlm.nih.gov/39102410,
PubMed,[PLoS Comput Biol] Impact of waning immunity against SARS-CoV-2 severity exacerbated by vaccine hesitancy,https://pubmed.ncbi.nlm.nih.gov/39102402,
PubMed,"[PLOS Glob Public Health] Mild and moderate COVID-19 during Alpha, Delta and Omicron pandemic waves in urban Maputo, Mozambique, December 2020-March 2022: A population-based surveillance study",https://pubmed.ncbi.nlm.nih.gov/39102391,
PubMed,[J Med Chem] Non-Covalent Inhibitors of SARS-CoV-2 Papain-Like Protease (PLpro): In Vitro and In Vivo Antiviral Activity,https://pubmed.ncbi.nlm.nih.gov/39102360,
